The Innovation and Value Initiative's open-source tool for measuring the value of prescription drugs could serve as a counterpoint to the assessments conducted by the Institute for Clinical and Economic Review and others.
Known as the Open-Source Value Project, the tool was introduced in the fall with funding from the health consultancy Precision Health Economics, a number of individual drug companies, the Pharmaceutical...